September 27, 2019
According to the latest study titled ‘Global Bone Replacement Market Growth 2019-2024’ available with Market Study Report LLC, the global bone replacement market is estimated to accumulate US $24300 million by the year 2024.
Bone replacement is done for restoring the damaged bone by implanting a bone graft sourced from other parts of the body (autografts), from cadavers (allografts), or by replacing the damaged bone with either ceramic or metallic alloys. In case of autografts, the bone availability is the key constraint as the amount of bone graft that can be used is limited.
According to this study, the bone replacement market was valued at US $19200 million in 2019 and is estimated to register a 4% CAGR over the projected time period. The study analyzes global bone replacement market for industry shares and growth opportunities by different segments. Furthermore, it provides an exhaustive understanding about trends, challenges, marketing strategies, distribution channels, consumer spectrum, and drivers influencing the market growth.
Based on type, the industry is segmented as hip replacement, knee replacement, and extremities. While based on application spectrum, the bone replacement market is divided as per the patient’s age, i.e., <45 years, 45 to 64 years, and 65+ years.
Considering the geographical landscape, bone replacement market is fragmented into four major regions as Europe, Americas, Middle East & Africa, and Asia Pacific. As per the report, USA was the largest consumer of bone replacement market with a recorded consumption share of 54% and revenue share of 57% in 2015. Europe held the second position with 24% consumption share and 25% revenue share in the same year. Moreover, China was the leading suppliers of bone replacement market with more than 2.9% revenue share and 6% consumption share in 2015.
Request sample copy of this Report@ https://www.marketstudyreport.com/request-a-sample/1629981/
Some of the vendors that operate in the global bone replacement market outlined in the report comprise of DePuy Synthes, Zimmer Biomet, Smith & Nephew, Stryker, Aesculap, Wright Medical, Mathys, Exactech, Lima Corporate, Waldemar LINK, Japan MDM, FH Orthopedics, JRI Orthopaedics, KYOCERA Medical, Baumer, Beijing AKEC, United Orthopedic, Beijing Jinghang, and Beijing Chunlizhengda.